BLIS Technologies Ltd
NZX:BLT
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
BLIS Technologies Ltd
NZX:BLT
|
NZ |
|
H
|
Hi Special Purpose Acquisition Co VIII
KOSDAQ:450050
|
KR |
|
S
|
Societe Generale SA
XMUN:SGE
|
FR |
|
S
|
Saipem SpA
F:SPE
|
IT |
|
E
|
Enbridge Inc
XMUN:EN3
|
CA |
Intrinsic Value
Is BLT undervalued or overvalued?
See the intrinsic value estimate for
BLIS Technologies Ltd and find out whether today’s valuation is cheap or expensive by its own historical standards.
Do our valuations actually work? See backtest results .
Fundamental Analysis
What BLIS Technologies Does
BLIS Technologies makes probiotic products based on naturally occurring bacteria strains that it developed for oral and throat health. It sells these strains and finished products, such as lozenges, capsules, and powders, through pharmacies, health retailers, distributors, and online channels. Its customers are mainly consumers looking for everyday health support, plus businesses that use BLIS strains in their own branded products.
- Headquarters
- New Zealand NZ
- Employees
- 39
- IPO date
- Jul 30, 2001
Earnings Waterfall
BLIS Technologies Ltd
The intrinsic value for
BLIS Technologies Ltd (BLT) under the Base Case is hidden NZD.
Compared with the current market price of 0.025 NZD, the stock appears hidden.